Sarah Svenningsen1,2,3, Nanxi Zha1, Rachel Eddy2, Dante Capaldi2, Melanie Kjarsgaard3, Katherine Radford3, Parameswaran Nair1,3, and Grace Parraga2
1McMaster University, Hamilton, ON, Canada, 2Robarts Research Institute, Western University, London, ON, Canada, 3Firestone Institute for Respiratory Health, St Joseph’s Healthcare, Hamilton, ON, Canada
Synopsis
Previous work suggests that inhaled gas
MRI conceals minable features that are distinctly different between severe
asthma inflammatory endotypes and these may be used to predict inflammatory
endotype. We evaluated the performance of inhaled gas MRI ventilation defect
percent, ventilation coefficient of variation and texture features to
discriminate severe asthmatics with and without the eosinophilic inflammatory
endotype. MRI measurements of ventilation significantly discriminated asthmatics
with eosinophilic inflammation from those without eosinophilic inflammation. Non-invasive
MRI-based biomarkers and signatures of asthma inflammatory endotype may serve
to guide treatment selection in individual asthmatics or evaluate the
effectiveness of anti-inflammatory treatments in clinical trials.
Introduction
Pulmonary
functional MRI is sensitive to airway inflammation1 and may provide a
way to indirectly stratify asthmatics according to their underlying disease mechanisms or “endotype”.
This is important because nearly 80% of severe asthmatics also have evidence of
airway inflammation. Endotype-specific anti-inflammatory drug discovery and
development is underway for such patients2 but currently
available measurements are poor predictors of treatment response, necessitating
the development of sensitive and precise biomarkers. Beyond inhaled gas MRI
ventilation defect percent (VDP), pulmonary functional MRI provides a wide
variety of minable image features and these may be considered for the prediction
of asthma inflammatory endotypes and the measurement of treatment response. Therefore,
our objective was to evaluate the performance of inhaled gas MRI VDP,
ventilation coefficient of variation (VenCOV) and texture features3 to discriminate
severe asthmatics with and without eosinophilic inflammation.Methods
We
evaluated asthmatics with eosinophilic inflammation (sputum eosinophils ≥3%4) and without
eosinophilic inflammation (sputum eosinophils <3%4) who provided
written-informed-consent and underwent spirometry and hyperpolarized 3He
MRI pre- and post-bronchodilator during a single visit. Eosinophilic inflammatory
endotype was confirmed using quantitative cytometry of induced sputum.5
Anatomical 1H and hyperpolarized 3He MRI were acquired
using a 3.0 Tesla Discovery MR750 system (General Electric Health Care, WI,
USA), as previously described.6 Patients were
instructed to inhale 1.0L of gas (100% N2 for 1H MRI and
a 3He/N2 mixture for 3He MRI)
from functional residual capacity, and coronal slices were acquired under
breath-hold conditions.
3He MRI static
ventilation segmentation was performed to generate VDP,6 VenCOV7
and second-order ventilation texture features long-run emphasis (LRE) and
long-run and low gray-level emphasis (LRLGE) were also generated as previously
described.3
Unpaired t-tests were used to compare
measurements between asthmatics with and without eosinophilic inflammation. Receiver
operating characteristic (ROC) analysis, from which the area under the curve
(AUC) was calculated, was used to measure the performance of VDP,
VenCOV, LRE and LRLGE as eosinophilic inflammatory endotype classifiers. Linear
discriminant analysis8 was subsequently performed
to build a composite signature comprised of all significant eosinophilic inflammatory
endotype classifiers. The optimum cut-off point was determined according to the
maximum Youden’s index value and the corresponding sensitivity, specificity,
positive and negative likelihood ratios were calculated. All statistics were
performed using GraphPad Prism version 7.00 (GraphPad, Inc., San Diego).Results
Patient characteristics and MRI measurements are provided in Table 1 for
16 asthmatics with eosinophilic inflammation (sputum eosinophils ≥3%) and 11
without eosinophilic inflammation (sputum eosinophils <3%). The two
subgroups were not different with respect to age, body mass index, or asthma
characteristics including asthma control and the forced expiratory volume in
one second (FEV1). Figure 1 shows MRI ventilation images for a representative
asthmatic with (sputum eosinophils=42%) and without eosinophilic inflammation (sputum
eosinophils=2%). As shown in Table 1, the subgroups were significantly
different with respect to post-bronchodilator VDP (p=0.004), VenCOV (p=0.02), LRE
(p=0.02) and LRLGE (p=0.02). ROC curves for each of the potential MRI eosinophilic
inflammatory endotype classifiers, including our derived composite signature, are
shown in Figure 2. MRI VDP (AUC=0.78; p=0.01), VenCOV
(AUC=0.74; p=0.03), LRE (AUC=0.76;
p=0.03), LRLGE (AUC=0.74; p=0.03) and the
derived composite signature (AUC=0.82; p=0.006) significantly discriminated
asthmatics with eosinophilic inflammation from those without eosinophilic
inflammation. For each classifier the established cut-off and the corresponding
performance characteristics (sensitivity, specificity, positive and negative
likelihood ratios) were: VDP: >5%, 0.63, 1, ∞, and 0.4; VenCOV: >0.22,
0.94, 0.45, 1.7, and 0.1; LRE: <836, 0.81, 0.73, 3.0, and 0.3; LRLGE: <717,
0.81, 0.73, 3.0, and 0.3; and composite signature: >1.3, 0.69, 0.91, 7.6,
and 0.3.Discussion
MRI measurements of ventilation significantly discriminated asthmatics
with eosinophilic inflammation from those without eosinophilic inflammation. We
subsequently used these patients as a training dataset to derive an MRI-based
signature of the eosinophilic inflammatory endotype consisting of VDP, VenCOV,
LRE and LRLGE. Our signature was not validated on an independent dataset,
therefore subsequent studies are required to confirm its performance.Conclusion
To our knowledge this is the first demonstration that higher order
texture features of pulmonary functional MRI stratified asthmatics based on eosinophilic
inflammation. These findings are relevant for clinical research and asthma clinical care
because novel
treatments that target specific disease mechanisms do not benefit all patients.
Non-invasive MRI-based signatures of asthma inflammatory endotype may
serve to guide treatment selection in individual asthmatics or evaluate the
effectiveness of novel anti-inflammatory treatments. Additional studies are required to integrate
and understand the importance of shape-based MRI ventilation features in asthma
endotype classification. Studies will then be required to determine if MRI-based radiomic signatures can guide personalized
treatment decisions in severe asthma. Acknowledgements
We thank M. Kjarsgaard and C. Huang for helping with the recruitment and
assessment of patients, K. Radford and N. LaVigne for the sputum cytometry, D. Capaldi
and H. Young for production and dispensing of 3He gas, and D. Reese
for MRI of research volunteers. References
1. Svenningsen S, Eddy RL, Lim HF et al. Inflammatory and
Non-Inflammatory Contributions to Ventilation Heterogeneity in Severe
Poorly-Controlled Asthmatics. Am J Respir Crit
Care Med. 2017; A2665.
2. Aleman F, Lim HF and Nair P. Eosinophilic Endotype of Asthma.
Immunol Allergy Clin North Am. 2016;36:559-568.
3. Zha N, Pike D, Svenningsen S et al. Second-order Texture Measurements of 3He Ventilation MRI:
Proof-of-concept Evaluation of Asthma Bronchodilator Response. Acad Radiol.
2016;23:176-185.
4.
Nair P and Hargreave FE. Measuring bronchitis in airway
diseases: clinical implementation and application: Airway hyperresponsiveness
in asthma: its measurement and clinical significance. Chest. 2010;138:38-43.
5. Pizzichini E, Pizzichini MM, Efthimiadis A et al. Indices of airway inflammation in induced sputum: reproducibility
and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996;
154:308-317.
6. Kirby M, Heydarian M, Svenningsen S et al. Hyperpolarized
3He magnetic resonance functional imaging semiautomated segmentation. Acad Radiol.
2012;19:141-152.
7. Sheikh K, Paulin GA, Svenningsen S et al. Pulmonary
ventilation defects in older never-smokers. J Appl Physiol. 2014;117:297-306.
8. Pudil P, Novovičová J and Kittler J. Floating search methods
in feature selection. Pattern Recognition Letters. 1994;15:1119-1125.